Benitec Biopharma Inc. - Common Stock, par value $0.0001 (BNTC)

CUSIP: 08205P209

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class
Equity / Common Stock, par value $0.0001
Total 13F shares
32,392,773
Total 13F value
$345,066,052
Holder snapshot 6 signals
Share change
+676,426
SEC-reported price per share
$10.65
Number of holders
88
Value change
+$4,592,772
Number of buys
55
Number of sells
21
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,393,481

Security key

08205P209

Report period

Q1 2026

Institutions

88

Top holders

10

BNTC full security history Ownership snapshot Full 13F holder table Previous quarter: Q4 2025 Benitec Biopharma Inc. SEC filings Benitec Biopharma Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BNTC - Benitec Biopharma Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SUVRETTA CAPITAL MANAGEME...
Disclosed value leader
SUVRETTA CAPITAL MANAGEME...
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G 3/4/5 13F Lead comparable stake: 44% 13D/G row: SUVRETTA CAPITAL MANAGEMENT, LLC Showing 1-6 of 15 holder rows.

Quick read

SUVRETTA CAPITAL MANAGEMENT, LLC leads the comparable SEC ownership view at 44%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SUVRETTA CAPITAL MANAGEMENT, LLC's linked filing trail.
Comparable ownership Top 5
SUVRETTA CAPITAL MANAGEMENT, LLC 44%
FRANKLIN RESOURCES INC 11%
JANUS HENDERSON GROUP PLC 10%
RA CAPITAL MANAGEMENT, L.P. 5.5%
HBM Healthcare Investments (Cayma... 4.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SUVRETTA CAPITAL MANAGEMENT, LLC
13D/G 3/4/5 13F
Director, 10%+ Owner · Company
13D/G 3/4/5 13F
44%
$249,200,088
17,761,945 shares
 +$30,000,153 07 Nov 2025
FRANKLIN RESOURCES INC
13D/G 13F
Company
13D/G 13F
11%
$50,561,782
3,751,709 shares
 -$5,287,404 31 Dec 2025
JANUS HENDERSON GROUP PLC
13D/G 13F
Company
13D/G 13F
10%
$44,484,293
3,382,836 shares
 -$292,158,468 28 Nov 2025
RA CAPITAL MANAGEMENT, L.P.
13F 13D/G
Company
13F 13D/G
5.5%
from 13D/G
$24,919,500
1,850,000 shares
 — 31 Dec 2025
HBM Healthcare Investments (Cayman) Ltd.
13D/G
13D/G
4.5%
$14,156,282
1,041,669 shares
 $0 31 Dec 2024
Nantahala Capital Management, LLC
13D/G 13F
Company
13D/G 13F
4.4%
$14,111,462
1,038,371 shares
 $0 31 Mar 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
88
Shares
32,392,773
Rows available
88
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
71
Q1 2026 holders
88
Holder diff
17
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 value Q1 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .